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Abstract
Many theoretical models have been proposed to explain the relationship between severe mental illness (SMI) and substance
use. Because many of these are contradictory quantitative American studies, a qualitative, exploratory study of a
Scandinavian sample may offer a new perspective. The aim of the study is to explore reasons for substance use through
analysis of the participants’ experiences. A qualitative study with semistructured interviews was used. Purposeful sampling
(N11) of patients with substance use disorder (SUD) and SMI, who were included in assertive community treatment
teams, was completed. Inclusion criteria are increased quality of life or increased general functioning, and decreased
substance use, after a minimum of 12 months in treatment. Reasons given for using substances were categorized as (a)
controlling the symptoms of mental illness, (b) counteracting medication side effects, or (c) balancing the ambiguity. The
conclusion is that the study findings mainly support secondary substance use models in explaining the comorbidity of SMI
and substance use. However, there is some support for the traditional self-medication hypothesis (SMH), iatrogenic
vulnerability, and the supersensitivity model. This may be because the majority of the study participants reported having a
mental illness with subsequent substance use. The expressed ambivalence to substance use also lends some support to
bidirectional models.
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Both epidemiological (Kessler et al., 1996; Regier
et al., 1990) and clinical studies (Duke, Pantelis, &
Barnes, 1994; Ziedonis & Trudeau, 1997) indicate
that persons with severe mental illness (SMI) are
more likely to have a substance use disorder (SUD)
than others. It is likely that these persons benefit
from traditional treatment to a lesser degree than
others and show a poorer prognosis concerning
both mental illness and SUD and that the substance
use has implications for both the treatment and
course of mental illness (Blanchard, Brown, Horan,
& Sherwood, 2000; Buckley, 2006; Dixon, Haas,
Weiden, Sweeney, & Frances, 1990). Individuals with
schizophrenia who use drugs have a higher risk of
hospitalization than those who abstain from drugs;
they have a higher risk of suicide and are more prone
to homelessness (Cohen, Test, &Brown, 1990;Drake
et al., 1990). Themost commonly used substances for
persons with a diagnosis of schizophrenia or other
psychotic disorders are cannabis, alcohol, and stimu-
lants (Atakan, 2008; Dixon et al., 1990; Koskinen,
Lo¨ho¨nen, Koponen, Isohanni, & Miettunen, 2010).
Qualitative studies show that individuals diagnosed
with SMI experience substance use as having a
negative impact on mental illness (Charles &Weaver,
2010; Cruce, O¨jehagen, & Nordstro¨m, 2008). How-
ever, there are other studies where participants held
strong beliefs on the use of substances to self-
medicate, to relax, and as a break from illness (Asher
& Gask 2010; Francoeur & Baker, 2010). Further
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along this line, the argument is that the subjective
expressions of individuals with schizophrenia to use
drugs seem to be that they perceive themselves as self-
medicating symptoms (Dixon et al., 1990). A recent
mixed-method study shows that relief of dysphoria
was the most frequently endorsed reason for sub-
stance use. Furthermore, they found that few parti-
cipants reported alcohol and cannabis use asmeans to
alleviate psychotic symptoms or to medicate side
effects (Thornton, Baker, Johnson, Kay-Lambkin, &
Lewin, 2012).
Several types of theoretical models attempt to
explain the increased substance use by individuals
with psychotic disorders: Common factor models
propose that one or more factors independently
increase the risk of both mental illness and substance
use. Bidirectional models hypothesize that either
disorder can increase vulnerability to the other
disorder. Secondary psychopathology models argue
that substance use causes psychiatric disturbances
that would otherwise not have developed. Finally,
secondary substance use models claim that the high
rates of comorbidity are the consequence of primary
SMI leading to SUD (Moggi, 2005; Mueser, Drake,
& Wallach, 1998). With regard to SMI, most
empirical research is found on the latter model,
although there is a considerable amount of research
on cannabis use precipitating mental illness.
As one of the secondary substance use models, the
traditional self-medication hypothesis (SMH) assumes
that specific substances are used to alleviate specific
symptoms of the psychosis and to gain relief from
negative affect and stress (Khantzian, 1985, 1997).
The hypothesis has been referred to in several
studies (Bizzarri et al., 2009; Phillips & Johnson,
2001; Schneier & Siris, 1987). Although it has little
support in clinical research (Mueser et al., 1998),
several studies on clients’ self-reports point to the
relief of dysphoria as a motivational factor for
substance use (Addington & Duchak, 1997; Dixon
et al., 1990; Spencer, Castle, & Michie, 2002). By
focusing on emotional states rather than symptoms,
and less on specific substances to address specific
symptoms, the general version of the SMH is more
in line with the alleviation-of-dysphoria model.
Often mentioned in relation to the SMH is the
reasoning that use of antipsychotic medication can
cause a state of vulnerability that causes or legi-
timizes the use of non-prescribed drugs (Khantzian,
1997). Some studies support the theory of iatrogenic
vulnerability (Costain, 2008; Duke et al., 1994;
Schneier & Siris, 1987; Spencer et al., 2002).
A literature review on self-reported reasons for
substance use showed the side effects of medication
to be an important motivational factor for substance
use in several of the studies (Gregg, Barrowclough,
& Haddock, 2007).
The supersensitivity model claims that increased
biological vulnerability to the effects of substance
use can explain some of the comorbidity of these
disorders (Moggi, 2005; Mueser et al., 1998). Sup-
portive of the model are findings that individuals with
dual disorders seem to use lower quantities of
substances than those with primary SUD (Lehman,
Myers, Corty, & Thompson, 1994) and that small
amounts of substances are likely to induce psychiatric
symptoms among clients with SMI (Drake, Osher, &
Wallach, 1989). Few clients with SMI are able to
sustain moderate substance use over time without
experiencing negative symptoms (Drake & Wallach,
1993). Among the different etiological models of
secondary substance use, research seems to provide
the strongest support for the supersensitivity
model and partly the alleviation-of-dysphoria model
(Mueser et al., 1998). However, many of the theore-
tical models that try to explain the relationship
between SMI and substance use are contradictory,
quantitative studies based on US samples.
Participants for our study were selected from five
of the assertive community treatment (ACT) teams
established in Norway in 20072010. A qualitative
study from a Norwegian setting may contribute by
exploring how the persons themselves describe the
reasons for their use of substances. The main dis-
cussion in the article views the participants’ experi-
ences of substance use in light of different theoretical
models that seek to explain the comorbidity. Few
studies describe how persons with SMI explain their
use of substances. This article seeks to fill a gap in
the contemporary literature. The aim of the study is
to explore reasons for substance use through analysis
of the participants’ experiences.
Methods
This study used a descriptive and explorative design,
aiming to create knowledge about individuals’ ex-
perienced life and subjective meanings. The objec-
tive was to describe how the participants’ substance
use is experienced and reflected upon in order to
shed light on the reasons for substance use as a
subjective phenomenon.
Recruitment and ethical aspects
A strategy of criterion-based, purposeful sampling
was used to recruit patients from five ACT teams
throughout Norway (Patton, 2002). Contact was
first established by telephone with the team leaders
of the five teams that had the most experience as
ACT teams and that had included the most patients.
H. Pettersen et al.
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This contact was followed by an e-mail with written
information explaining the purpose of the study. The
e-mail requested permission for the first author to
interview patients who met the inclusion criteria for
the study: persons with simultaneous SUD and SMI
who were included in ACT teams, and who had
increased quality of life or better functioning, or a
decrease in substance use (as defined by both the
patient and the team), after a minimum of 12
months of treatment. Current substance use was
assessed using the Alcohol Use Identification Test
(AUDIT) and Drug Use Disorders Identification
Test (DUDIT) when the patient joined the ACT
team, and problematic substance use was considered
meeting the inclusion criteria of an SUD.
The team leaders recruited the participants by
asking the rest of the team if they had patients who
met the inclusion criteria for the study. We do not
know exactly how many patients were asked to
participate and how many refused to take part in
the study. However, our impression was that most of
those who were asked did agree. Two of the teams
that did not contribute participants to the study had
recruited three more patients, but they were not
included because the sample size was already suffi-
cient. The team leaders also made appointments for
the interviews.
The relationship with some of the participants was
rather fragile in the sense that revealing too many
difficulties and private issues during the interviews
could lead to later feelings of distress. This was
expressed by some of the participants as well as by
some of the team leaders. Therefore, it was arranged
that the first author, who performed all the interviews
for this study, would report back to the team on the
progress of all patients after the second interview
without disclosing the content of the interviews.
The study was approved by the Regional Commit-
tee for Medical and Health Research Ethics, South-
East Region (no. 1196, 2010), before patients were
invited to participate. Each individual gave written
informed consent to participate in the study.
Participants
Eleven patients (nine men and two women) met the
inclusion criteria. At the time of the first interview, the
age range was 2763 (mean age39 years). Most
participants had a long history of SMI, with subse-
quent substance use. Only one participant was unsure
whether his substance use preceded his psychotic
disorder or vice versa.Themajority of the participants
had a diagnosis of schizophrenia, but some indivi-
duals had bipolar disorder and unspecified psychosis.
All participants had a history of using substances,
mainly amphetamine and cannabis, and, to a lesser
extent, alcohol and prescription drugs. Four partici-
pants had quit substance use by the time of the
interviews. One of those had also injected heroin. The
seven participants who were still using substances
mainly reported using amphetamine, cannabis, and
alcohol, in nearly equal amounts, and mostly in a
mixture of use. One reported using only prescription
drugs (e.g., benzodiazepines and codeine). Few
of them seemed to use substances on a daily basis.
Most typical was to take some substances 34 times a
week, often in connection with lapses in their mental
illness. The majority of the participants had originally
been medicated with antipsychotics to treat their
mental illness, but only one of them was on forced
medication.
The majority of the participants lived alone, and
most of them were in rented flats owned by the
municipality. Only two of the participants were em-
ployed part-time in government-subsidized work,
but some were about to start full-time work or had
plans to complete a certificate of apprenticeship.
Three had unfinished culinary qualifications. All of
the participants had experienced different treatment
settings due to both their mental illness and their
substance use before they were included in an ACT
team. At the time of the first interview, the length of
treatment in the team ranged from 14 to 36 months
(mean treatment time22 months).
Interviews
The first individual interviews were completed
between August and November 2011, and the
second interviews, with nine of the 11 participants,
were completed between February and June 2012.
The interval between the first and second interviews
was 58 months. One participant was considered by
his therapist to be unable to complete a second
interview because of a relapse, and one participant
did not meet at the scheduled time of the interview.
A total of 20 interviews were conducted; 11 took
place in a meeting room frequently used by the ACT
team, six were performed in the participants’ homes,
and three took place in an in-patient setting. The
duration of each interview ranged from 45 to 75
minutes, and most interviews were recorded with
a digital sound recorder. One of the participants
objected to the use of recording devices during the
interview, so data from this interview were recorded
in written notes. Most participants required one or
two breaks during the interview. Most interviews
were on a one-on-one basis, but on two occasions a
nurse or therapist accompanied the participant for
safety or support reasons. On the first occasion, a
clinical nurse was present during the interview due
to safety reasons. The participant had on some
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occasions displayed aggressive behavior. The pre-
sence of the nurse seemed not to influence what was
talked about, and the interviewer felt confident in his
presence. On the other occasion, a clinical psychol-
ogist attended the interview for supportive reasons
on request from the participant. The participant
described a close relationship to the psycholo-
gist and addressed him twice during the interview.
But overall, this interview also progressed so that
significant information was passed on. The second
interview with both participants was conducted
without assistance from the therapists.
An interview guidewith specified topicswas used to
focus on the relevant experiences of the participants,
including reasons for the use of the substance, positive
and negative aspects of substance use, and how
substance use influenced their mental illness. Probing
questions were used to further explore the issues that
were brought up. Two of the participants did not
accept, or seemed unaware of, their psychiatric
condition. Hence, asking how substance use influ-
enced their mental illness was difficult. But both of
them could express how substance use influenced
their mental state*concerning, for example, depres-
sive thoughts, anxiety, or well-being*without agree-
ing on their diagnosis of schizophrenia. In most
instances, each interview was transcribed, and a
transcription memo taken, before interviewing the
next participant.
The reasons for doing a second interview were to
explore important issues not covered during the first
encounter, clarify information given in the first
interview, and have the opportunity to more thor-
oughly examine specific topics. The follow-up inter-
views provided a longitudinal dimension. It has been
stated that reporting to respondents what they have
said in a previous interview elicits better data
(Farrall, 2006). However, having several months
between the interviews was disadvantageous in that
most participants found it hard to recall what they
talked about in the first interview. To ease the
memory, each participant read a transcript summary
from the first interview or was presented with main
points from the transcription of the first interview as
an aid to call to mind important issues from the first
encounter. Their feedback formed the basis of the
subsequent theme development in the second inter-
view and served as a means of internal validation
(Aronson, 1994). Furthermore, none of the partici-
pants reconsidered or contradicted what they had
brought up during the first interview.
Analysis
The interview transcripts were analyzed using sys-
tematic text condensation (Malterud, 2012), a
pragmatic approach inspired by phenomenological
psychology (Giorgi, 2009). This includes a stepwise
procedure that aims to identify recurring initial
codes and themes relevant to the purpose of the
study. The method is recommended for descriptive
and explorative analyses of a phenomenon in reports
from different participants. Its use is also suggested
when developing new descriptions of a phenom-
enon. An inductive approach was intended in the
sense that the identified themes were strongly linked
to the data themselves (Charmaz, 2006).
The first author carried out the data collection
and performed most of the analysis. By having the
ACT teams recruiting patients for the study, the first
author (interviewer) knew nothing more of the
participants than their gender, their psychiatric
diagnosis, and that they were engaging in substance
use when included in the team. The first author,
trained as a clinical nurse and with a master’s degree
in health promotion, focused on factors influencing
progress and well-being. The interview transcripts
were read with an open mind, as a means to bracket
the researcher’s preconceptions and with focus on
what the participants conveyed.
Notes taken after each interview made it easier in
the consecutive interviews to remind the interviewer
to ask questions and give prompts that were more
tailored to each participant, be prepared for the
physical environments, and reserve an appropriate
amount of time and prepare for convenient breaks to
conduct each interview.
To sort out and organize the interview data, the
software program NVivo 10 (QSR International Pty
Ltd., 2012) was utilized in the theme development
after the initial codes were identified. Initially, the
interview transcripts were read through to search for
expressions viewed as important aspects contribut-
ing to improvement. A total of 115 expressions
(initial codes) were identified. Further searches for
familiarity and diversity among the initial codes
resulted in six overarching themes covering the
whole data set. The main theme, Different aspects of
substance use, was selected for analysis and covered
all of the expressions from the participants concern-
ing substance use. Because of the large number of
meaning units within this main theme, it was split
into Substance use as a coping strategy and Experiences
of abstaining from substance use. The former theme
was selected for further analysis. A total of 43
meaning units, consisting of sentences or paragraphs
from the transcripts, were identified. The meaning
units were organized into three subthemes, and a
text of condensed meaning was constructed for each
one. The last phase consisted of summarizing the
meaning of the content in a new description.
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Most of the initial coding and initial theme
development were done by HP, but AL and ER
contributed significantly in the identification of
codes in the initial phase, and through the later
theme development.
Results
The findings emphasize the different reasons that
participants gave for their substance use, and they
are classified in relation to different models to
explain the co-occurrence of SMI and substance
use. Both former and present users contributed to
the findings. Below, the participants’ expressions are
reported and discussed in accordance to the follow-
ing subthemes: controlling the symptoms of mental
illness, counteracting medication side effects, and balan-
cing the ambiguity.
Controlling the symptoms of mental illness
Although some of the reasoning for substance use
was as a way to relax or get high, this was not the
main reason for substance use in our study. Instead,
the focus was on experiences of emotional states and
how these were influenced by substance use. Some
of the participants who used, or had used, alcohol
regularly explained that the main purpose was to
decrease anxiety and depression, and/or to take a
break from everything that was difficult. The use of
alcohol was viewed as less harmful than the use of
illegal substances, while other expressions under-
scored a preference for cannabis or amphetamines,
mentioning alcohol in negative terms and suggesting
it caused problems for individuals as well as for
society.
Reasons for substance use were seen as both a way
to escape unwanted conditions and a way to create a
shift of focus. Often-cited reasons were to get a break
from experienced difficulties, and this was expressed
through the use of different substances. Concepts
used to illustrate this were break, interruption, seda-
tion, and escape. Some of them had established
strategies to implement these timeouts in their
everyday life on a predetermined time schedule,
while others just did it when it felt right.
One participant (Participant 1, or P1) had used
alcohol for many years in a conscious strategy to
manage severe distress:
Twenty-four days can pass, then the 12 beers
eliminate all the problems, give me a timeout.
Being drunk takes me to another place where I’m
happy, can start over again and begin on another
24 days. Then, another 12 beers. That’s how my
life goes. God would thank me for making it
through another period. (P1)
Other expressed reasons for using alcohol were to
calm down and/or to sleep at night. The use of
benzodiazepines was described as creating a general
state of calm and daze, even when hearing internal
voices. The use of prescribed drugs was not a big
issue for those who participated, and their use
seemed to be associated with the use of other
substances. Cannabis was viewed specifically as a
way to cope with the hearing of voices. In most cases,
this was mentioned in relation to alleviating states of
extremely loud and dominant voices. One participant
also explained that cannabis had a more calming
effect on the voices than the use of antipsychotic
medication. He described how substance use affected
his mental illness:
Hash helps me calm my inner voices when they
get loud. I feel it’s the only medicine that helps.
Better to smoke dope than to drink alcohol.
Fluanxol can also help me with the voices but
not all the time. Dope, on the other hand, affects
me deeply. It penetrates into my bones and all
around me. The THC [tetrahydrocannabinol] in
the dope encases itself around my bones, enhances
my senses by making them pure in everyday
settings. (P6)
The use of amphetamines seemed to have several
functions. Other given reasons were the use of
amphetamine to regulate, or even induce, the manic
states of a bipolar disorder. The mania under the
influence of amphetamines was perceived to be less
troublesome than other manic episodes. One parti-
cipant, who was diagnosed with bipolar disorder,
started using substances as an adult and described
his strategy of using amphetamines in the following
manner:
Mymanic periods are experienced differently when
I’m high on amphetamines compared to when I’m
not. Being high makes me feel stronger during my
manic phases. Amphetamines help me achieve a
manic phase that is similar to amanic phasewithout
amphetamines. The dope helps me identify and
learn from the symptoms in a manic phase. If I
didn’t, then the manic phases would come less
often and Iwould not be able to copewith them [the
manic phases] when they come. (P9)
Because controlling and stabilizing efforts are
important in coping with his illness, amphetamines
become an agent to induce more frequent, but less
dramatic, manic episodes. Other given reasons were
Self-reported substance use and severe mental illness
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the calming effects of amphetamines when hearing
voices; amphetamines seemed to be more potent
than cannabis in this respect.
The urge to have substances was strongly related
to the episodes and fluctuations associated with
mental illness. The need to take substances seemed
to be less urgent when symptoms of the psychotic
disorder did not dominate. As one participant
pointed out:
I don’t need to get high all the time. I feel I need to
get high when I get the tiresome fluctuations
[swings]. I can also calm myself down with some
coffee and a cigarette, without the need of drugs.
Things have changed a bit, I have more control
now. (P6)
Experiences of ups and downs seem to be the
nature of severe mental disorders. Some expressions
indicated that the illness developed more or less
independently of the substance use. The illness was
something that could not be cured, but the sub-
stance use could be seen as a strategy to make life
worth living.
Counteracting medication side effects
Amphetamines seemed to be the preferred substance
to address the experienced side effects of antipsy-
chotics. Statements about substance use reflected
the need to create more ‘‘awake’’ days, as antipsy-
chotic medication imposes a drowsy state and an
urge to sleep both day and night.
One participant described himself as a former
polydrug user. He reflected on his substance use
after being abstinent for several months:
Getting high on amphetamines wasn’t so bad.
Zyprexa caused my anxiety and made me sleepy.
I started using amphetamines to do something
about the side effects of my antipsychotic medi-
cines. I remember that I slept so much that all I
wanted was a day or a weekend where I was
awake. (P3)
Gaining weight is a well-known side effect of these
medicines, and some of the reasoning expressed the
use of amphetamines as a slimming strategy. In some
instances, this extended into its use as a strategy to
increase well-being and stimulate the courage to
participate in social activities. In comparison, one
participant had his own strategy in the sense that he
himself made the decision to quit the use of
antipsychotics, more or less against advice from his
psychiatrist. Being abstinent for the last 2 years after
using some amphetamines, but mainly alcohol, to
relieve anxiety, he explained:
My medicines caused my weight gains. They
suppressed my feeling of fullness. It felt like I
was hungry at all times and [so I] ate. After that
period, I stopped taking my medication and went
from 115 kg to 85 kg. I function better without
medication than I did when I was on them. My
cravings for alcohol also disappeared. My quality
of life is better now after I quit using both alcohol
and my medicine. (P4)
Instead of continuing to use alcohol to counter the
unwanted effects of the medicines, he stopped using
antipsychotics. His strategy had an extensive im-
pact*he did not need either alcohol or ampheta-
mines to manage his daily life.
Expressed reasons for the use of amphetamines
seem to imply increased substance use in periods of
heavy medication. The rationale expressed for this
use implied an attitude of stubbornness in not fully
agreeing with the use of medication. In a wider
sense, the participants emphasized the need to be in
charge of their own lives. To some extent, the
medication seemed to create a sort of imbalance,
and amphetamine use was claimed to help restore
this balance. This reflects the views that ampheta-
mines were considered to be the polar opposite of
antipsychotics and that a kind of equilibrium was
gained through this strategy.
One participant, who was diagnosed with bi-
polar disorder, expressed his reasons for using
amphetamines:
Yeah, I can envision a life without getting high . . .
a fantastic life without amphetamines. But taking
Cisordinol and being dependent on it, feeling blue
and emotionally flat . . . like the last ten years,
makes it real hard to quit using amphetamines.
(P9)
He had been on medication for several years, but
the use of substances (mainly amphetamines) started
later in his life. This can be seen as an example of
informed choice in the sense that he has experienced
SMI both with and without substance use, and he
decided on the latter to manage his life.
Balancing the ambiguity
Reasons given for substance use contained elements
of ambivalence or ambiguity. The same substance
had different meanings, effects, and consequences
for different individuals, and the overall perspective
seemed to applaud the positive short-term effects of
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taking substances but at the same time showed
awareness of the adverse long-term consequences.
Substance use seemed to create problems but, at the
same time, produced better functioning in different
arenas. All over, reasons for substance use reflected
ambivalence towards which consequences substance
use have for daily life.
Some expressions indicated that amphetamines
contributed to create energy and activity in daily
life, but at the same time led to unpleasant tremors
and later deterioration of well-being. One par-
ticipant described the very effective way that am-
phetamines helped him to lose weight, but it was
too fast. He appreciated the fantastic effects of
the substance but, at the same time, feared the
consequences:
I lost weight, but using amphetamines now
doesn’t make me feel any better; I sometimes
use hash so I do not become too thin, it is better to
lose weight slowly. I can’t wait to get to a more
stable weight where I feel better about myself.
Taking amphetamines makes it easier for me to
live. But it is not healthy to be constantly in this
situation. (P6)
There were also statements about the impact of
substance use on mental illness. Broadly speaking,
there seemed to be more worries concerning the
amount of substances being used than about the
adverse effects inherent in the specific substances.
Some expressions on the use of substances to self-
medicate unpleasant states and symptoms reflected
the risk of a worsening of mental illness and
becoming psychotic. One participant commented
on how substance use may lead to both well-being
and deterioration:
I don’t think getting high really affects my mental
problems. I feel that I am more functional when
I’m high, while at the same time there is a danger
of taking too much and ending up in a psychotic
state. (P7)
This awareness of the harmful effects of substance
use can be transferred to the ambivalent view on
antipsychotic medication. This ambivalence was
displayed through expressions of the important
contribution of antipsychotics to help participants
improve, and at the same time complaints about its
adverse effects. One of the participants described his
experiences of being in active psychosis under the
influence of amphetamines as quite different from
active psychosis without the substance. He described
the risks and benefits associated with amphetamine
use in severe states of his illness. Also prevalent were
expressions of the negative influence of substance-
using environments, even in periods of abstinence.
Expressions of ambiguity seemed integrated when
weighting the advantages of substance use against
the adverse effects. Several of the participants could
easily recall the negative influence of the substance-
using environment, and they couldn’t fully believe
the sobriety was going to last.
Despite most of the substances being illegal, and
despite all of the negative consequences connected
to substance use, substances were being used.
Expressions were prevalent of life as a struggle of
conflicting emotions with unpredictable outcomes.
One description contains experiences of being both
abstinent and an active user of substances:
Even though I’ve had drug-free periods, my life
hasn’t gotten any better. I am still fighting the
same fight. Not that it’s any better when I’m on
drugs. (P7)
Personal narratives of the impact of substance use
on daily life reflect the basic uncertainty that the
participants experienced in their lives. Substance use
leads to both well-functioning and malfunctioning
outcomes for those trying to keep up with the
demands of family, therapists, and the greater
society while facing SMI symptoms.
Discussion
The aim of this explorative study was to examine the
reasons for substance use through the participants’
experiences. The analysis showed different views on
substance use. First, active use could be seen mainly
as a means to self-medicate the symptoms of mental
illness or to alleviate the adverse effects of antipsy-
chotics. Second, ambivalent use indicated both the
experienced positive and negative consequences of
different substances.
Reasons for substance use were stated mainly as a
strategy for managing difficult emotional states and
severe symptoms. What is important in this study is
that the same substances served different purposes
for different individuals. For instance, ampheta-
mines were used for their calming effect after hearing
voices, to compensate for emotional flattening, and
as a slimming strategy. All of these views were
expressed by individuals with similar psychiatric
diagnoses.
Findings from our study can be seen as supportive
of the traditional SMH (Khantzian, 1985, 1997)
because specific substances were used to cope with
specific symptoms or emotional states. This is
inconsistent with a review of self-report studies
showing that substances were used to alleviate states
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of dysphoria (Gregg et al., 2007), rather than that
specific substances were used to handle specific
symptoms. Our results also differ from those of
two other studies on patients’ perspectives (Charles
& Weaver, 2010; Cruce et al., 2008), which found
that substance use was considered to have mainly
negative effects on SMI. In contrast, reasons given in
our study were that, to a large extent, substance use
contributes to better management of mental illness
(e.g., managing manic episodes, coping with the
hearing of voices, calming down the participants,
and providing energy). Another crucial finding is
that several of the expressions pointed to the
importance of taking a break from the challenging
facets of life. This was done either as a conscious and
scheduled strategy, or as a kind of self-help on the
basis of experienced dysphoria. However, it is
unclear what can be viewed as symptoms, emotional
states, and dysphoria (Henwood & Padgett, 2007).
The main difference between the findings in the
reported studies and ours was that the participants
in the reported studies generally had a primary
SUD, while participants in our study had several
years of SMI with subsequent substance use. This
may be critical in explaining the differences between
the findings. One important aspect could also be
that the majority of participants in our study did not
report any negative effects of substance use, prob-
ably because few of them ever experienced severe
substance use. Another difficulty arises when taking
into account that the traditional SMH of Khantzian
is based on research on users of heroin and cocaine
in an American setting, although his reconsideration
of the model (Khantzian, 1997) evolves from diag-
noses to emotional states, and he takes into con-
sideration several other substances. The expressions
communicated in the current study are consistent
with the traditional SMH, containing descriptions on
how different substances affected difficult emotional
states, and indicate that substance use was pro-
longed despite negative long-term effects. However,
the use of different substances to alleviate similar
distress among different individuals could also
imply that the chosen substance was influenced by
availability.
The importance of substance use in coping with
the adverse effects of medication was communi-
cated, despite the fact that medication was not a
separate issue asked about in the interviews. Iatro-
genic vulnerability to antipsychotic medication is
one model that attempts to explain the comorbidity
of SMI and SUD. The theory is based on the
mechanism of antipsychotics, which block some
types of dopamine receptors in the brain in order
to control psychotic symptoms. This could result in
an underactive dopamine reward system and in-
creased vulnerability to substance use (Stahl, 2008).
According to Drake, Xie, McHugo, and Green
(2000), there is some evidence to support this
model, since there is a tendency for clients treated
with second-generation antipsychotics to use a
smaller amount of substances than those treated
with traditional antipsychotics. The rationale is that
traditional antipsychotics block more of the dopa-
mine receptors than those developed later. Expres-
sions given in our study indicate that there are quite
divergent views on the impact of antipsychotics.
Because medication was explored in the context of
substance use in this study, it is possible that the
adverse effects of medication were focused on. Some
of the participants also spoke of antipsychotics as
necessary and helpful in stabilizing their lives, but
never as a remedy that was purely advantageous.
The findings of the current study indicate that
substances were used for self-medication and/or to
relieve side effects of medication, and, in this
respect, the findings oppose findings from other
studies concerning the use of alcohol and cannabis
(Addington & Duchak, 1997; Thornton et al.,
2012). In these studies, participants reported on
the use of both alcohol and cannabis as contributing
to a worsening of the positive symptoms of psycho-
sis. There are several possible reasons why this was
not found in the present study. Participants in the
Thornton study (Thornton et al., 2012) were
considered to have relatively high functioning and
did not go through personal interviews, while
participants in the current study were ‘‘hard-to-
reach’’ clients in an assertive outreach setting.
Addressing the use of amphetamines in the present
study may add important information about the
reasons for substance use. There are arguments
regarding the protective agency of antipsychotics
against the neurotoxic effects of amphetamines
(Bramness et al., 2012), although the participants’
use of amphetamines counteracts the effects of anti-
psychotics. According to Bramness et al. (2012),
psychosis also seems to be precipitated by a lower
dose of amphetamines in individuals with primary
psychosis and may be blocked by the use of anti-
psychotics. No literature was found to shed light on
clients’ experiences of using substances when medi-
cated with antipsychotics.
Prominent in the present study were expressions
of the importance of taking the right substance in
a proper way to minimize adverse effects. In this
respect, amphetamines were the most preferred
substance. Views on the scope and extent of the
use of stimulants are not prominent in the research
literature. There are few studies on how individuals
with psychotic disorders use and experience the
effects of amphetamines (Nolte, Wong, Latchford,
H. Pettersen et al.
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Boyle, & Anaenugwu, 2012), although some re-
search indicates that individuals diagnosed with
schizophrenia may more readily become psychotic
after their use (Lieberman, Kane, & Alvir, 1987).
One central aspect of the supersensitivity model is
that both genetic and early environmental events
interact with later environmental stressors to con-
tribute to psychiatric disorders or to trigger relapses
(Mueser et al., 1998). An extension of this argument
implies that medications can decrease vulnerability,
while substance use can increase it. Participants in
our study also point to experiences of going into
psychosis when taking too much of a substance. The
balance has to be maintained. It seems that after
years of experiencing life with SMI, they were aware
of their limits. They seemed to use a limited amount
of substances, and they had experienced more
positive than negative effects. In this respect, the
findings support the supersensitivity model.
Some expressions convey that substance use
increased during bad periods of the mental illness.
In periods of reduced symptoms or emotional
distress, the need to take substances was also
reduced. This could imply some support to the
bidirectional models, which claim that mental illness
and SUD can have reciprocal influences on one
another. In contrast, participants also stated that the
mental illness itself seemed to develop more or less
independently of the substances being taken. It
seemed necessary for the participants in this study
to be in control of their substance use. Their
experiences of well-being versus distress were made
up of a mixture of substance use, medications, and
symptoms of mental illness. It could also be argued
that secondary psychopathology models may explain
some of the substance use, such as in the reported
episodes in which substance use led to a worsening
of symptoms. However, this seems to be of less
concern to the participants in our study because
most indicated that their mental illness preceded
their substance use. The limited amount of sub-
stances being used also gives poor support for the
latter model.
Furthermore, findings from our study partly con-
trast previous research on patients’ perspectives. One
study (Cruce et al., 2008) found that the desire to use
drugs declined when patients were struggling against
symptoms of mental illness and that substance use
decreased their thinking capacity. Reasons given
in our study are contrary. Particularly, the use of
cannabis and amphetamines could dampen the hear-
ing of voices and promote clear thoughts. The latter is
similar to findings from other studies on cannabis
use by individuals diagnosed with schizophrenia
(Costain, 2008; Francoeur & Baker, 2010). Sub-
stance use in order to have a break from a difficult and
monotonous life was stated as a reason in our study
concerning the use of alcohol, cannabis, and amphe-
tamine. Similar findings are reported in studies on
cannabis use (Costain, 2008; Francoeur & Baker,
2010) and on polydrug use (Asher & Gask, 2010).
Findings in the study of Charles and Weaver (2010)
indicate that substance use has a negative impact on
mental illness and that, among the reasons given for
trying a substance, the relief of psychotic symptoms
was never included. Our study did not examine why
the participants initiated their substance use but
mainly investigated reasons for why they kept on
using. Contrary to the present study, the other studies
cited here had samples where a majority of the
participants was, or had been, into heavy substance
use, and SUD for most of them had preceded the
SMI. One important question is whether substance
use is viewed in more positive terms when the SMI
occurs before the SUD, and therefore as more of a
solution than a problem.
Clinical implications
With regard to self-medication, clinicians should be
aware of clients using substances to relieve symptoms
of mental illness. Specific substances can be used to
counteract both positive and negative symptoms of a
psychotic disorder. Established procedures are re-
quired in assessments to ask about substance use and
the function that the substances have. Clinicians need
to motivate the user/patient to reduce the use of
substances, and the patients need to get treatment for
anxiety and depression. How to live with voice hear-
ing is also important in treatment. In general, to
use evidence-based psycho-educative approaches
and integrated dual disorder treatment (Mueser,
Noordsy, Drake, & Fox, 2003) is essential. Assessing
substance use, and how and why clients use sub-
stances, is just as important as which substances they
use. It is possible that less severe use, such as shorter
durations and lower amounts, may be of importance
in understanding the relationship between substance
use and psychotic disorders. Assessments should also
take into account whether substance use has preceded
the mental illness or vice versa, as this seems to
influence clients’ perception of their substance use.
When treating clients with antipsychotics, clinicians
should carefully consider the adverse effects of
the medications. Some individuals with SMI seem
to have a better life when using substances than
when abstaining from them. In some cases, this may
mean working in collaboration with the clients to
minimize rather than eliminate substance use. Clin-
icians should expand their awareness to meet such
challenges.
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Limitations
This is an exploratory study, and the interpretations
of the data should be considered within the context
of qualitative research. The fact that the study
sample consists mainly of individuals with substance
use secondary to SMI may limit the potential to
explain the comorbidity in terms of etiological
models outside secondary substance use models.
Persons with less severe SUD may idealize their
substance use and, retrospectively, report fewer
negative aspects. The findings are partly based on
the participants’ memories of former substance use,
and could therefore be susceptible to bias. However,
to explore reasons for substance use as a subjective
phenomenon involves focus on the meaning the
participants give their substance use. The reports
on the use of both legal and illegal substances rely on
the openness and honesty of the participants.
Conclusion
This qualitative study, which focused predominantly
on participants with primary SMI, sheds light on the
reasons for substance use by individuals with SMI in
an assertive outreach setting. Substance use was
experienced as having a mostly positive effect on
symptoms of mental illness, when substances were
taken at the right time and in a reasonable amount.
The findings mainly support the traditional SMH, but
they also partly support the explanatory model of
supersensitivity and iatrogenic vulnerability to antipsy-
chotics. Bidirectional models could also explain some of
the participants’ ambivalence regarding their sub-
stance use. Further research may explore how clients
diagnosed with schizophrenia and bipolar disorder
experience substance use in general, and how they use
substances to alleviate the adverse effects of antipsy-
chotic medication. Overall, more research is needed
of SUD, both primary and secondary to SMI.
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